Professional Reference articles are designed for health professionals to use. You may find the Cystic Fibrosis article more useful, or one of our other health articles. NICE has issued rapid update guidelines in relation to many of these. This guidance is changing frequently. Cystic fibrosis CF is a multi-organ disease best managed in a multidisciplinary setting in conjunction with a specialist centre for CF, with treatment tailored to the individual.
Our bodies contain various different types of mucus. These are usually useful, even important, to us in a wide number of ways. They help to protect us from disease, protect us from damage, and also help provide lubrication when needed. Mucus is produced in glands that are found all over the body. Cystic fibrosis is a genetic condition that causes mucus glands to secrete mucus that is thicker than usual. This can cause it to accumulate in the body and this can lead to a range of potentially serious complications. There is, as yet, no known cure for cystic fibrosis but treatment is available that can at least help to ease symptoms.
Following previously received positive recommendations from the Pharmaceutical Benefits Advisory Committee PBAC , eligible patients in Australia will be able to access both medicines immediately, and the medicines will be listed on the Pharmaceutical Benefits Scheme PBS from December 1 st. About CF Cystic Fibrosis CF is a rare, life-shortening genetic disease affecting approximately 75, people worldwide. CF is a progressive, multi-system disease that affects the lungs, liver, GI tract, sinuses, sweat glands, pancreas and reproductive tract.
People with cystic fibrosis CF infected with the new coronavirus appear to have better outcomes than initially anticipated, with their COVID disease following a course similar to that of the general population, an international study suggests. This research also points to a lower incidence of coronavirus infections in this patient group compared to the public-at-large, possibly due to a lifelong adherence to social distancing and other measures that mitigate an infection risk. CF patients are believed to be highly vulnerable to SARS-CoV-2 infections, not only because their disease chronically affects the lungs, but also because of comorbidities. About one-third of patients develop other conditions, such as diabetes , that appear to increase the risk of severe coronavirus infections. To avoid contracting the virus, these people are being advised to stay at home at all times, avoiding contact with anyone outside their household.